State Institute for Drug Control

29. 04. 2022

Opinion of SUKL´s Department of Clinical Trials of Medicinal Products from the 22 November 202 will expire on the 23 May 2022.

29. 04. 2022

List of reimbursed medicinal products valid as of 1.5.2022

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...

13. 04. 2022

UST-29 version 22

06. 04. 2022

PHV-6 version 3

06. 04. 2022

PHV-4 version 8

31. 03. 2022

List of reimbursed medicinal products valid as of 1.4.2022

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...

10. 03. 2022

SÚKL´s opinion on the inclusion of Ukrainian patients in clinical trials in the Czech Republic

28. 02. 2022

List of reimbursed medicinal products valid as of 1.3.2022

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...